Contracts Finder · Planning
Lanadelumab
A public procurement published by NHS ENGLAND via Contracts Finder.
Contracts FinderPlanning
- —
- Award value
- £12m
- Tender value
- 0
- Suppliers
- 0
- Awards
- 8
- Notices
- Planning
- Stage
Overview
Lanadelumab
Key details
- Buyer
- NHS ENGLAND
- Source
- Contracts Finder
- Lifecycle stage
- Planning
- Status
- planned
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- —
- Tender value
- £12,000,000
- First published
- 4 Aug 2020
- Last updated
- 2 Nov 2021
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from NHS ENGLAND
Products for the treatment of Haemophilia A
Planning · Contracts FinderNHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care
Planning · Contracts FinderNHS Framework Agreement for the supply of products for the teratment of Haemophilia A
Planning · Contracts FinderNHS National Framework Agreement for the supply of Haemophilia A
Planning · Contracts FinderAdult Influenza Vaccines - Secondary Care
Planning · Contracts FinderNHS Framework Agreement for the Supply of Human Normal Immunoglobulin & Anti-D Immunoglobulin
Planning · Contracts FinderFAQs about this procurement
Who is the buyer for "Lanadelumab"?
Lanadelumab is a UK public-sector procurement published by NHS ENGLAND via Contracts Finder.
Has "Lanadelumab" been awarded?
No award has been recorded yet. The current lifecycle stage is "Planning".
What is "Lanadelumab" worth?
The reported tender value is £12,000,000.
When was "Lanadelumab" published?
It was first published on 4 Aug 2020 and last updated on 2 Nov 2021, across 8 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable